Ann: NYR Advances Xolatryp Phase IIa Trial in Cardioprotection, page-35

  1. 1,619 Posts.
    lightbulb Created with Sketch. 231
    when they have a 12 billion dollar unmet market growing 10 percent year in year with no drug company capable of doing what we do your looking at a multi billion dollar license deal with a 500 million dollar upfront payment based on similar deals in the recent biotech space, to do as many additional indications fully funded. Enjoy the time ahead
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
-0.003(0.84%)
Mkt cap ! $70.10M
Open High Low Value Volume
29.5¢ 29.5¢ 28.0¢ $156.4K 537.2K

Buyers (Bids)

No. Vol. Price($)
1 2500 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 259493 4
View Market Depth
Last trade - 15.24pm 12/08/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.